Jonathan R. Kerr

3.6k total citations
63 papers, 2.5k citations indexed

About

Jonathan R. Kerr is a scholar working on Infectious Diseases, Dermatology and Psychiatry and Mental health. According to data from OpenAlex, Jonathan R. Kerr has authored 63 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 25 papers in Dermatology and 15 papers in Psychiatry and Mental health. Recurrent topics in Jonathan R. Kerr's work include Parvovirus B19 Infection Studies (29 papers), Dermatological and COVID-19 studies (25 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers). Jonathan R. Kerr is often cited by papers focused on Parvovirus B19 Infection Studies (29 papers), Dermatological and COVID-19 studies (25 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers). Jonathan R. Kerr collaborates with scholars based in United Kingdom, United States and Canada. Jonathan R. Kerr's co-authors include Derek L. Mattey, D. A. J. Tyrrell, A Rutman, Graham W. Taylor, P J Cole, Robert Wilson, Niels Høiby, Faraj Barah, David J. Fear and Selwyn Richards and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Jonathan R. Kerr

62 papers receiving 2.4k citations

Peers

Countries citing papers authored by Jonathan R. Kerr

Since Specialization

Citations

This map shows the geographic impact of Jonathan R. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Kerr more than expected).

Fields of papers citing papers by Jonathan R. Kerr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan R. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Kerr. The network helps show where Jonathan R. Kerr may publish in the future.

Co-authorship network of co-authors of Jonathan R. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan R. Kerr. A scholar is included among the top collaborators of Jonathan R. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan R. Kerr. Jonathan R. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME) 2016 ·PLoS ONE ·Robert Petty, Neil E. McCarthy, Rifca Le Dieu, Jonathan R. Kerr	36
2	Le dernier C: centré sur la médecine familiale 2012 ·Canadian Family Physician ·Elizabeth Shaw, Allyn Walsh, Danielle Saucier, David Tannenbaum, Jonathan R. Kerr, (unknown), Jill Konkin, (unknown), Ivy Oandasan	1
3	Continuity: middle C--a very good place to start. 2011 ·Europe PMC (PubMed Central) ·Jonathan R. Kerr, Allyn Walsh, Jill Konkin, David Tannenbaum, (unknown), (unknown), Danielle Saucier, Elizabeth Shaw, Ivy Oandasan	17
4	Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome 2010 ·Retrovirology ·Harriet C. T. Groom, Virginie Boucherit, (unknown), Edward Randal, (unknown), Suzanne Hagan, John Gow, Frank Mattes, Judith Breuer, Jonathan R. Kerr, Jonathan P. Stoye, Kate N. Bishop	141
5	Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder 2010 ·Neuropathology and Applied Neurobiology ·(unknown), Jonathan R. Kerr, (unknown), Alan Maclean, Margarita V. Chibalina, (unknown), Beverley Burke, Steve Bevan, Jamal Nasir	55
6	Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis 2009 ·Journal of Clinical Pathology ·(unknown), John Gough, David Christmas, Derek L. Mattey, Selwyn Richards, Janice Main, Derek Enlander, D. Honeybourne, Jon G. Ayres, David Nutt, Jonathan R. Kerr	67
7	Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis 2008 ·The Journal of Infectious Diseases ·Jonathan R. Kerr, Robert Petty, Beverley Burke, John Gough, David J. Fear, Lindsey I. Sinclair, Derek L. Mattey, Selwyn Richards, Jane Montgomery, Don A. Baldwin, Paul Kellam, Tim J. Harrison, George E. Griffin, Janice Main, Derek Enlander, David Nutt, Stephen T. Holgate	106
8	Preexisting Psychological Stress Predicts Acute and Chronic Fatigue and Arthritis following Symptomatic Parvovirus B19 Infection 2008 ·Clinical Infectious Diseases ·Jonathan R. Kerr, Derek L. Mattey	22
9	Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome 2005 ·Journal of Clinical Pathology ·Nagendra Kumar Kaushik, David J. Fear, Selwyn Richards, Clare McDermott, Emile F. Nuwaysir, Paul Kellam, Tim J. Harrison, Robert J. Wilkinson, D. A. J. Tyrrell, Stephen T. Holgate, Jonathan R. Kerr	111
10	Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia: Table 1 2003 ·Journal of Clinical Pathology ·Jonathan R. Kerr, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	39
11	Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection 2003 ·Journal of Clinical Pathology ·Jonathan R. Kerr, (unknown), (unknown), (unknown), (unknown), (unknown)	41
12	Cytokines in parvovirus b19 infection as an aid to understanding chronic fatigue syndrome 2003 ·Current Pain and Headache Reports ·Jonathan R. Kerr, D. A. J. Tyrrell	28
13	Neurological manifestations of human parvovirus B19 infection 2003 ·Reviews in Medical Virology ·Faraj Barah, Pamela Vallely, G.M. Cleator, Jonathan R. Kerr	50
14	Semiquantitative Polymerase Chain Reaction Enzyme Immunoassay for the Diagnosis of Pertussis 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·Ruth Matthews, (unknown), Wolfram Manuel Brück, David J. Owen, (unknown), V. Weston, Jonathan R. Kerr	11
15	Parvovirus B19 infection in AIDS patients 1997 ·International Journal of STD & AIDS ·Jonathan R. Kerr, (unknown), Brendan Crowley, (unknown), S. O’Briain, Peter Coyle, F Mulcahy	17
16	Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection 1996 ·Journal of Medical Virology ·Jonathan R. Kerr, Peter Coyle, Robert Deleys, (unknown)	27
17	The antibiotic cost calculator; an expert system for global antibiotic cost calculation 1995 ·Computer Methods and Programs in Biomedicine ·Jonathan R. Kerr	2
18	Parvovirus B19 Infection - Persistence and Genetic Variation 1995 ·Scandinavian Journal of Infectious Diseases ·Jonathan R. Kerr, Martin D. Curran, John E. Moore, Philip G. Murphy	24
19	Design and production of a target-specific monoclonal antibody to parvovirus B19 capsid proteins 1995 ·Journal of Immunological Methods ·Jonathan R. Kerr, Hugh J. O’Neill, Robert Deleys, Christopher Wright, Peter Coyle	10
20	An outbreak of parvovirus b19 infection; a study of clinical manifestations and the incidence of fetal loss 1994 ·Irish Journal of Medical Science (1971 -) ·Jonathan R. Kerr, H. J. O’Neill, Peter Coyle, William C. Thompson	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact